View Cart (0 items)

Pharmaceutical

Wyeth Had Illegal Patents on Effexor Per Lawsuit

The Associated Press reports that a federal lawsuit filed this week in Mississippi claims a major pharmaceutical company made millions of dollars by misrepresenting clinical data and using sham litigation
Read More

BioMarin to Buy Pfizer Plant

Zacks Equity Research reports that BioMarin Pharmaceutical Inc.will acquire an integrated biologics manufacturing plant from Pfizer Inc., which will expand its manufacturing capacity to manage its product portfolio and its
Read More

AstraZeneca Sells Dental Business for $1.8 Billion

The Associated Press reports, AstraZeneca PLC is selling its Astra Tech dental business, the world''s third-largest maker of dental implants, for $1.8 billion, the Anglo-Swedish pharmaceutical company announced Wednesday. The
Read More

Single-Use Mixer Improves BioPharm Process Efficiency

The Allegro™ 200L Single-Use Mixer is designed for high-performance mixing in biopharmaceutical applications from pilot scale to full production. The unit improves the efficiency of critical mixing processes throughout the
Read More

Pfizer Lung Cancer Pill May Double Survival

The Associated Press reports that a much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according
Read More

Pfizer Asks EU to Approve Kidney Cancer Drug

The Associated Press reports that Pfizer Inc. has asked European Union regulators to approve its drug candidate axitinib as a treatment for kidney cancer. Pfizer wants approval to market axitinib
Read More

Optimer Wins US Approval for Drug to Fight Fatal Bacteria

According to Bloomberg, Optimer Pharmaceuticals won FDA approval for the first antibiotic in a quarter-century that fights a deadly bacterium linked to intestinal infections often caught in hospitals. Optimer will
Read More

Syngenta Launches New Seed Treatment

According to PRNewswire, Syngenta announced the launch of VIBRANCEā„¢, a proprietary seed treatment fungicide based on the new active ingredient sedaxane. VIBRANCE, which has been tailored specifically for the seed
Read More

Japan''s Takeda Buying Nycomed for $13.6 billion

The Associated Press reports that Takeda Pharmaceutical Co. will buy Switzerland''s Nycomed for $13.6 billion, giving Japan''s biggest drugmaker coveted access to emerging markets. The all-cash deal is the largest
Read More

Amylin Pharmaceuticals Files Suit Against Eli Lilly

PRNewswire reports that Amylin Pharmaceuticals, Inc. has filed a lawsuit against Eli Lilly and Company in the United States District Court for the Southern District of California, alleging that Lilly
Read More